Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A drug having the chemical formula C26H25F9N2O4, which was originally planned for use against hypercholesterolemia but is no longer in development

Etymologies

Sorry, no etymologies found.

Examples

  • After 16 years and nearly $800 million in research, Pfizer halted development of a Lipitor successor called torcetrapib because of patient deaths in trials.

    Pfizer's Future: A Niche Blockbuster

  • A compound called torcetrapib raised so-called good cholesterol, and Pfizer championed it—right up to the moment that a board monitoring the testing learned it was increasing patients' risk of dying.

    Drug Makers Refill Parched Pipelines

  • "He was dealt a difficult hand when a promising cholesterol drug called torcetrapib failed and there was no successor to Lipitor," Funtleyder said, adding, "He might have done a better job."

    Pfizer CEO Kindler, 55, Unexpectedly Replaced

  • Pfizer abruptly halted development of a similar drug called torcetrapib four years ago, in an $800 million debacle.

    Cholesterol Drug Advances

  • The company had banked on another cholesterol-lowering drug, called torcetrapib, to provide a new source of growth.

    Pfizer Plans to Abandon

  • Late last year, Pfizer lost its brightest hope on this front, a drug called torcetrapib that raised so-called good cholesterol and was personally championed by Mr. LaMattina, after that drug was linked to safety problems in premarket tests.

    Pfizer Picks Insider as New Science Chief

  • But much of the focus in Pfizer's pipeline is on a single drug, torcetrapib, which is designed to raise good cholesterol and clear plaque out of arteries.

    Transforming Pfizer?

  • Neither drug caused high blood pressure, a problem that helped doom Pfizer's own CETP inhibitor, called torcetrapib.

  • It is still early days for dalcetrapib, and medical experts remain wary following the high-profile failure of a similar drug from Pfizer called torcetrapib.

  • It is still early days for dalcetrapib, and medical experts remain wary following the high-profile failure of a similar drug from Pfizer, called torcetrapib, in 2006.

    FOXNews.com

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.